Organization in Acute Atrial Fibrillation Post Open Heart Surgery

Atrial Fibrillation Clinical Trial

— A-Fib  

Official title:

Organization in Acute Atrial Fibrillation Post Open Heart Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00614107
• Other study ID #: 5301UMU
• Status: Completed
• Start date: January 2008
• Est. completion date: January 2009

Study information

• Verified date: January 2008
• Source: State University of New York - Upstate Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A form of irregular heart rate called, Atrial Fibrillation (AF) is a major clinical problem. It afflicts about 2 million Americans and is the single largest heart related cause of stroke. However, despite 120 years of speculation and research, the mechanisms that cause AF are poorly understood. Acute AF is also the most common irregular heart rate after open-heart surgery in patients. This is seen in as many as 30% of such patients and often results in a longer hospital stay.

In this study we would like to study the pattern of atrial fibrosis (scar tissue in the heart) and an associated blood marker (a protein called pro-collagen-1) in those patients concurrently having open heart surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: January 2009
• Est. primary completion date: January 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 79 Years

Eligibility

Inclusion Criteria:

1. 18 years of age, Male or Female

2. Able to provide consent

3. Cardiac surgery, CABG of Valve replacement or repair.

Exclusion Criteria:

1. If AF terminates within 1 hour of initiation.

2. If the patient undergoes electrical cardioversion and/or receives digitalis within the first hour of inclusion.

3. If the patients and/or their family or the primary caregiver choose to be excluded from the study anytime, even after the initial 24-hour period.

4. If the patient expires within 1 hour of inclusion into the study. -

Related Conditions & MeSH terms

• Atrial Fibrillation

Locations

Country	Name	City	State
United States	SUNY Upstate Medical University	Syracuse	New York

Sponsors (1)

Lead Sponsor	Collaborator
State University of New York - Upstate Medical University

Country where clinical trial is conducted

United States,